Company
Zealand Pharma
Nasdaq Copenhagen: ZEAL
Danish biotech founded in 1998, based in Søborg near Copenhagen. Develops peptide therapies for gastrointestinal and metabolic disease.
1 story
Regulatory News has published 1 story about Zealand Pharma on 24 September 2026, sourced to the primary record — the regulator’s decision, the company’s filing or its own announcement. This page is generated from that coverage. Last updated 24 September 2026.
This page is generated from Regulatory News’ editorial coverage of Zealand Pharma. It is not an advertisement.
On the record
- Company
- Zealand Pharma A/S (Nasdaq Copenhagen: ZEAL)
- Headquarters
- Søborg, Copenhagen, Denmark
- Founded
- 1998
- Regulator
- European Medicines Agency (CHMP)
- Latest milestone
- CHMP positive opinion, Zeydovio (glepaglutide)
Each line is taken from the most recent story of ours that states it.
Products in our coverage
Our coverage
